Stephanie Scheidt, MD
Obstetrics · Harrisonburg, VANPI 1871706911
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 30.6% of the total. Reporting peaked in 2021 at $236 and has fallen 73.6% since, to $62 in 2024.
Across 56 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$290
- Organon$198
- Astellas Pharma US Inc$78
- Merck$74
- Bayer$63
- Currax Pharmaceuticals LLC$59
- plus $186 from 9 others
What the payments were for
- Food & beverage$948100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 17 | $290 |
| Organon | 9 | $198 |
| Astellas Pharma US Inc | 5 | $78 |
| Merck | 5 | $74 |
| Bayer | 3 | $63 |
| Currax Pharmaceuticals LLC | 4 | $59 |
| Avion Pharmaceuticals | 2 | $27 |
| Pfizer | 2 | $27 |
| Mycovia Pharmaceuticals, Inc. | 2 | $26 |
| Therapeuticsmd, Inc. | 2 | $24 |
| Coopersurgical, Inc. | 1 | $22 |
| Evofem Biosciences, Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Novo Nordisk | 1 | $13 |
| Amgen | 1 | $13 |
How this compares
$948 in reported general payments places this provider in the 55th percentile of 41 obstetrics providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 20 | $1,006 |
| Medroxyprogesterone Acetate | 16 | $88 |
| EstaryllaNorgestimate-Ethinyl Estradiol | 11 | $77 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in Harrisonburg
- Wade NeimanLynchburg$25K
- Teresa TanNewport News$9K
- Michael GrimesChesapeake$5K
- Bita MotesharreiMc Lean$4K
- Amy PorterFalls Church$3K
- Alexis LightAlexandria$3K
- Susan DauschRichmond$3K
- Michelle BennettNorfolk$3K
- Sharon KimAlexandria$2K
- Bridgett CasadabanFalls Church$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.